{"entity":{"id":"leukemia-lymphoma-society","kind":"collection","name":"Leukemia & Lymphoma Society (LLS)","aka":[],"tldr":"The Leukemia & Lymphoma Society is the main US blood-cancer charity, unusual for running its own precision-medicine trials (Beat AML, PedAL) and investing directly in biotech, alongside co-pay assistance and one-to-one information specialists.","summary":"Founded 1949. LLS funds ~$1.7 billion in research to date, runs Beat AML (genomic-assignment master trial that showed rapid genomic testing is feasible in AML, Nat Med 2020) and the paediatric PedAL/LLS Dare to Dream project, offers Information Specialists, the Clinical Trial Support Center (nurse navigators), co-pay assistance (>$500 million distributed), and advocacy on drug costs and oral parity. Its patient booklets cover every leukaemia, lymphoma, myeloma and MDS/MPN.","asOf":"2026-09-08","links":[{"label":"LLS","url":"https://www.lls.org/"},{"label":"Beat AML (Nat Med 2020)","url":"https://doi.org/10.1038/s41591-020-1089-8"}],"tags":["gap-fill","patient-org"],"related":["aml","all-leukemia","cll","cml","dlbcl","follicular-lymphoma","mantle-cell-lymphoma","hodgkin-lymphoma","multiple-myeloma","mds","myeloproliferative-neoplasms"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["lls-therapy-acceleration-program"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":["paper-burd-nat-med"],"journals":[],"dependsOn":[],"notes":[],"url":"https://www.lls.org/","holds":"Patient education and information specialists for blood cancers, co-pay and travel assistance programmes, the Beat AML and PedAL master trials, Therapy Acceleration Program venture funding, and clinical trial navigation.","license":"Copyright LLS","maintainer":"LLS"},"route":"/collections/leukemia-lymphoma-society/","neighbours":{"cancer":[{"id":"all-leukemia","kind":"cancer","name":"Acute lymphoblastic leukaemia","route":"/cancers/all-leukemia/"},{"id":"aml","kind":"cancer","name":"Acute myeloid leukaemia","route":"/cancers/aml/"},{"id":"cll","kind":"cancer","name":"Chronic lymphocytic leukaemia","route":"/cancers/cll/"},{"id":"cml","kind":"cancer","name":"Chronic myeloid leukaemia (CML)","route":"/cancers/cml/"},{"id":"dlbcl","kind":"cancer","name":"Diffuse large B-cell lymphoma","route":"/cancers/dlbcl/"},{"id":"follicular-lymphoma","kind":"cancer","name":"Follicular lymphoma","route":"/cancers/follicular-lymphoma/"},{"id":"hodgkin-lymphoma","kind":"cancer","name":"Hodgkin lymphoma","route":"/cancers/hodgkin-lymphoma/"},{"id":"mantle-cell-lymphoma","kind":"cancer","name":"Mantle cell lymphoma","route":"/cancers/mantle-cell-lymphoma/"},{"id":"multiple-myeloma","kind":"cancer","name":"Multiple myeloma","route":"/cancers/multiple-myeloma/"},{"id":"mds","kind":"cancer","name":"Myelodysplastic syndromes / neoplasms (MDS)","route":"/cancers/mds/"},{"id":"myeloproliferative-neoplasms","kind":"cancer","name":"Myeloproliferative neoplasms (PV, ET, myelofibrosis)","route":"/cancers/myeloproliferative-neoplasms/"}],"company":[{"id":"lls-therapy-acceleration-program","kind":"company","name":"Leukemia & Lymphoma Society Therapy Acceleration Program","route":"/companies/lls-therapy-acceleration-program/"}],"paper":[{"id":"paper-burd-nat-med","kind":"paper","name":"Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial","route":"/key-papers/paper-burd-nat-med/"}],"institution":[{"id":"ash","kind":"institution","name":"American Society of Hematology","route":"/institutions/ash/"}],"trial":[{"id":"beat-aml-master-trial","kind":"trial","name":"Beat AML Master Trial","route":"/trials/beat-aml-master-trial/"}]}}